key: cord-1015886-tz3adqeu
authors: Miró, Òscar; Llorens, Pere; Jiménez, Sònia; Piñera, Pascual; Burillo, Guillermo; Martín, Alfonso; Martín-Sánchez, Francisco Javier; del Castillo, Juan González
title: Frequency of five cardiovascular/hemostatic entities as primary manifestations of SARS-CoV-2 infection: Results of the UMC-19-S(2)
date: 2021-01-30
journal: Int J Cardiol
DOI: 10.1016/j.ijcard.2021.01.051
sha: cffcb320e61c5940d565fa089de63c947c9de89c
doc_id: 1015886
cord_uid: tz3adqeu

• Several cardiovascular/hemostatic disturbances haves been reported in patients with COVID-19, but the real frequency and their potential association with the pathogenic mechanisms of SARS-CoV-19 still remain to be defined. • We investigated the relative frequency of acute coronary syndrome, deep venous thrombosis, pulmonary embolism, stroke and upper gastrointestinal bleeding in COVID patents attending emergency departments (EDs), before hospitalization and compared them with frequencies in the general ED population attending 50 Spanish EDs. • We found that the risk of pulmonary embolism is clearly increased in COVID patients, with an OR of 4.53 with respect to non-COVID patients (95% confidence interval 4.03- 5.10). Additionally, the diagnosis of pulmonary embolism was 2 fold more frequent among ED comers in 2020 compared to 2019, suggesting a SARS-CoV-2 role in such increment of cases.. The remaining entities studied were not found to be unequivocally increased in the present study and need further investigation.

and lung infiltrates in more severe cases 1, 2 . Many patients also present a pro-coagulant state, which is biochemically detected by increased D-dimer levels and is related to complications and a worse prognosis 1, 3 . In this context, isolated case reports and short case series have suggested an increased risk of patients with COVID-19 to develop clinically relevant cardiovascular and hemostatic disturbances [3] [4] [5] [6] [7] .

Nonetheless, many of these reports refer to hospitalized patients, and as hospitalization itself usually increases complications in bedridden patients with multidrug treatment or in very poor condition, it is unknown if such cardiovascular/hemostatic processes are related to the pathogenesis of SARS-Cov-2. Focus on patients with COVID-19 at emergency department (ED) arrival could help to answer this question.

The and compare these frequencies with those observed in the overall ED population (non-COVID patients, controls Cardiovascular/hemostatic manifestations in cases and controls were first identified through the electronic system according to specific codes and were then manually reviewed in medical reports and confirmed by the principal investigator of each center. ACS included both myocardial infarction with or without ST elevation, and stroke included both ischemic and hemorrhagic events. The complete methodology has been extensively detailed elsewhere 8, 9 .

The relative frequency of the 5 above mentioned cardiovascular/hemostatic entities in ED comers in cases and controls was compared following two different strategies: 1) by comparing the relative frequency in COVID patients using non-COVID patients as comparator (altogether and also using the subgroups of non-COVID patients included in 2019 and 2020 separately); and 2) by comparing the relative frequency in 2020 with respect to 2019. In order to describe the main baseline patient characteristics, we collected age, sex and comorbidities for all cases presenting any of the 5 entities, and compared them with a sample of controls recruited by randomly selecting one control (1:1) with the same diagnosis from the entire list of controls. Comparisons were performed using the chi square or ANOVA test, as needed.

The Conclusions: PE was clearly increased in ED comers during the 2020 period, and this increase seems to be linked to SARS-CoV-2 infection. The role of SARS-CoV-2 in the mild increments observed in DVT, stroke and UGB needs further investigation.

J o u r n a l P r e -p r o o f Highlights Several cardiovascular/hemostatic disturbances haves been reported in patients with COVID-19, but the real frequency and their potential association with the pathogenic mechanisms of SARS-CoV-19 still remain to be defined.

We investigated the relative frequency of acute coronary syndrome, deep venous thrombosis, pulmonary embolism, stroke and upper gastrointestinal bleeding in COVID patents attending emergency departments (EDs), before hospitalization and compared them with frequencies in the general ED population attending 50

Spanish EDs.

We found that the risk of pulmonary embolism is clearly increased in COVID patients, with an OR of 4.53 with respect to non-COVID patients (95% confidence interval 4.03-5.10). Additionally, the diagnosis of pulmonary embolism was 2-fold more frequent among ED comers in 2020 compared to 2019, suggesting a SARS-CoV-2 role in such increment of cases.. The remaining entities studied were not found to be unequivocally increased in the present study and need further investigation.

J o u r n a l P r e -p r o o f

Hospital Regional Universitario de Málaga: Manuel Salido, Miguel Moreno Fernández. 57.-Hospital Lluís Alcanyís de

Josep Tost. 60.-Hospital de Denia (Alicante): Antonio Barceló. 61.-Hospital de

clinical characteristics of coronavirus disease 2019 in China

Profile of patients with COVID-19 treated in Spanish emergency departments during the 2020 pandemic

Clinical findings, risk factors, and final outcome in patients diagnosed with pulmonary thromboembolism and COVID-19 in hospital emergency departments

Venous and arterial thromboembolic complications in COVID-19 patients admitted to an academic hospital in

Acute pulmonary embolism associated with COVID-19 pneumonia detected by pulmonary CT angiography

Pulmonary embolism in COVID-19 Patients: Awareness of an increased prevalence

Coexistence of COVID-19 and acute ischemic stroke report of four cases

Collaboration among Spanish emergency departments to promote research: on the creation of the SIESTA (Spanish Investigators in Emergency Situations TeAm) network and the coordination of the UMC-19 (Unusual Manifestations of COVID-19) macroproject

Analysis of clinical characteristics and outcomes in patients with COVID-19 based on a series of 1000 patients treated in Spanish emergency departments

Collateral damage of COVID-19-lockdown in Germany: decline of NSTE-ACS admissions

Hospital attendance and admission trends for cardiac diseases during the COVID-19 outbreak and lockdown in Greece

Impact of the COVID-19 pandemic on acute myocardial infarction care times

Acute pulmonary embolism in COVID-19 disease: Preliminary report on seven patients

Pulmonary vascular endothelialitis, thrombosis, and angiogenesis in Covid-19

Manuscript Title:

List of all Authors: Òscar Miró, Pere Llorens, Sònia Jiménez, Pascual Piñera, Guillermo Burillo, Alfonso Martín, Francisco Javier Martín-Sánchez, Juan González del Castillo, on behalf of the Spanish Investigators on Emergency Situations TeAm (SIESTA) network

This statement is to certify that all authors have seen and approved the manuscript being submitted, have contributed significantly to the work, attest to the validity and legitimacy of the data and its interpretation, and agree to its submission to the International Journal of Cardiology.We attest that the article is the Authors' original work, has not received prior publication and is not under consideration for publication elsewhere. We adhere to the statement of ethical publishing as appears in the International of Cardiology (citable as: Shewan On behalf of all Co-Authors, the corresponding Author shall bear full responsibility for the submission. Any changes to the list of authors, including changes in order, additions or removals will require the submission of a new author agreement form approved and signed by all the original and added submitting authors.All authors are requested to disclose any actual or potential conflict of interest including any financial, personal or other relationships with other people or organizations within three years of beginning the submitted work that could inappropriately influence, or be perceived to influence, their work. If there are no conflicts of interest, the COI should read: "The authors report no relationships that could be construed as a conflict of interest". J o u r n a l P r e -p r o o f